CURRENT AFFAIRS

Detailed explanation-1: -Pune-based Serum Institute of India (SII) unveiled India’s first indigenously developed pneumococcal vaccine on Monday.

Detailed explanation-2: -Vaxneuvance is a pneumococcal 15-valent conjugate vaccine created by Merck that was approved for medical use in the United States in July 2021. The vaccine was developed under the code name “V114".

Detailed explanation-3: -Union Minister Dr Jitendra Singh announces India’s first indigenously developed vaccine, “CERVAVAC” for the prevention of cervical cancer.

Detailed explanation-4: -Union Health Minister Dr. Harsh Vardhan launched India’s first indigenously developed pneumococcal vaccine, ‘PNEUMOSIL’ manufactured by the Serum Institute of India.

Detailed explanation-5: -In 2015, NTAGI recommended that a PCV be introduced in India. Within seven months, the Indian government approved the recommendation, making it one of the fastest vaccines from evidence presentation to policy decision.